Brief: Dr. Lal Pathlabs Expands Genomics Capabilities With Illumina's Novaseq X Series
25/06/2025 10:02
June 25 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS: DR. LAL PATHLABS LTD - EXPANDS GENOMICS CAPABILITIES WITH ILLUMINA'S NOVASEQ X SERIES Source text: ID:nNSE32QPlQ Further company coverage: DLPA.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise